Novo Nordisk A/S | NOVOB - Selling And Administration Expenses

Stock Price
260.00
Daily Change
13.30 5.39%
Monthly
10.26%
Yearly
-35.56%
Q2 Forecast
247.42

Novo Nordisk reported DKK17.44B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Bausch Health Companies USD 801M 6M Dec/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
Eli Lilly USD 3.13B 391.3M Dec/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
Merck USD 2.85B 215M Dec/2025
Novartis USD 3.44B 128M Dec/2025
Novo Nordisk DKK 17.44B 1.41B Dec/2025
Novo Nordisk DKK 2.86B 13.25B Jun/2025
Pacira USD 91.87M 70K Dec/2025
Sanofi EUR 2.33B 419M Mar/2026
Supernus Pharmaceuticals USD 122.39M 57.29M Dec/2025